1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal

This week, Phispers brings to you the details of the bioelectronics firm formed by GSK and Google. T

Sandoz, Mylan, Hetero, Lupin face the heat due to data manipulation at Semler

In April 2016, the US Food and Drug Administration (FDA) came down heavily on Semler Research Center

The silver lining in Ipca’s Import Alert blues

Ipca Laboratories finished dosage facilities at Silvasa and Pithampur (India) were put on the FDA Im